SCHEMBL5239544

SCHEMBL5239544

CCOC(=O)c1sc(-c2cccnc2)nc1O

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC7 O00311 9/20 0.85
DBF4 Q9UBU7 9/20 0.85
TRPM8 Q7Z2W7 6/20 0.74
MAPT P10636 4/20 0.64
MEN1 O00255 3/20 0.61
KMT2A Q03164 3/20 0.61
KDM4E B2RXH2 2/20 0.60
HSP90AA1 P07900 1/20 0.60
CRHBP P24387 1/20 0.60
CRHR2 Q13324 1/20 0.60
NPC1 O15118 1/20 0.56
POLB P06746 1/20 0.56
NFKB1 P19838 1/20 0.56
RAB9A P51151 1/20 0.56
NFKB2 Q00653 1/20 0.56
RELA Q04206 1/20 0.56
LMNA P02545 1/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2C19 P33261 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2881465 0.89 CDC7 (0.72) CDC7DBF4TRPM8MAPTMEN1
Hydrochloric Acid SCHEMBL6201525 0.88 CDC7 (0.70) CDC7DBF4TRPM8MAPTMEN1
SCHEMBL17318008 0.86 CDC7 (0.73) CDC7DBF4TRPM8MAPTMEN1
SCHEMBL6338322 0.85 TRPM8 (1.00) CDC7DBF4TRPM8MAPTMEN1
SCHEMBL5240574 0.84 CDC7 (1.00) CDC7DBF4TRPM8MAPTMEN1
SCHEMBL290342 0.83 CDC7 (0.72) CDC7DBF4TRPM8MAPTMEN1
SCHEMBL17374860 0.83 TRPM8 (0.63) CDC7DBF4TRPM8MAPTMEN1
SCHEMBL20022399 0.81 CDC7 (0.62) CDC7DBF4TRPM8MAPTMEN1
SCHEMBL15049004 0.80 TRPM8 (1.00) CDC7DBF4TRPM8MAPTMEN1
SCHEMBL15049177 0.80 TRPM8 (0.76) CDC7DBF4TRPM8MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106715424-B Bicyclic compounds as pesticides 拜耳作物科学股份公司 2020-07-14 CN disclosed
EP-3152216-B1 BICYCLIC COMPOUNDS AS PESTICIDES BAYER CROPSCIENCE AG (DE) 2019-07-24 EP disclosed
US-10294243-B2 Bicyclic compounds as pesticides BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2019-05-21 US disclosed
US-10294243-B2 Bicyclic compounds as pesticides BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2019-05-21 US disclosed
US-20170101422-A1 Bicyclic compounds as pesticides BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2017-04-13 US disclosed
US-20170101422-A1 Bicyclic compounds as pesticides BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2017-04-13 US disclosed
US-20170101422-A1 Bicyclic compounds as pesticides BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2017-04-13 US disclosed
EP-3152216-A1 BICYCLIC COMPOUNDS AS PESTICIDES Bayer CropScience Aktiengesellschaft (DE) 2017-04-12 EP disclosed
WO-2015185531-A1 BICYCLIC COMPOUNDS AS PESTICIDES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2015-12-10 WO disclosed
WO-2015185531-A1 BICYCLIC COMPOUNDS AS PESTICIDES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2015-12-10 WO disclosed
EP-1507776-B1 2-OXO-1,3,4-TRIHYDROQUINAZOLINYL DERIVATIVES FOR THE TREATMENT OF CELL PROLIFERATION-RELATED DISORDERS AMGEN INC (US) 2007-02-28 EP disclosed
US-7119111-B2 2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use AMGEN, INC. (US) 2006-10-10 US disclosed
EP-1507776-A1 2-OXO-1,3,4-TRIHYDROQUINAZOLINYL DERIVATIVES FOR THE TREATMENT OF CELL PROLIFERATION-RELATED DISORDERS Amgen Inc. (US) 2005-02-23 EP disclosed
US-20030229068-A1 2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use AMGEN INC. 2003-12-11 US disclosed
WO-2003101985-A1 2-OXO-1,3,4-TRIHYDROQUINAZOLINYL DERIVATIVES FOR THE TREATMENT OF CELL PROLIFERATION-RELATED DISORDERS AMGEN INC. (US) 2003-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030229068-A1 2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use CASP3, BAX, BAD CDC7 893/4885DBF4 4312/4885TRPM8 4438/4885
US-10294243-B2 Bicyclic compounds as pesticides DDT, BCHE, CYCS CDC7 2198/4885DBF4 145/4885TRPM8 701/4885
US-20170101422-A1 Bicyclic compounds as pesticides DDT, BCHE, CYCS CDC7 2198/4885DBF4 145/4885TRPM8 701/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.